Compound information
- Natural Products
- ZC2139138
- Molecular Formula
- C18H19ClFN3O
- Molecular Weight
- 347.120068128 g/mol
- Structure
-
- IUPAC Name
- 4-[(4-chlorophenyl)methyl]-N-(3-fluorophenyl)piperazine-1-carboxamide
- InChI
- InChI=1S/C18H19ClFN3O/c19-15-6-4-14(5-7-15)13-22-8-10-23(11-9-22)18(24)21-17-3-1-2-16(20)12-17/h1-7,12H,8-11,13H2,(H,21,24)
- InChI Key
- ZZRAJRDCCYVXCN-UHFFFAOYSA-N
- SMILES
- O=C(Nc1cccc(F)c1)N1CCN(Cc2ccc(Cl)cc2)CC1
- Source
- ZINC000020437908
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 24 | Ring Count | 3 |
Heteroatom Count | 6 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 2 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 35.58 Å2 | LogP | 3.747 |
LogS | -3.922 | LogD | 4.159 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.996 | Pgp substrate | 0.825 |
HIA | 0.969 | F20 % | 0.993 |
F30 % | 0.983 | Caco-2 | -4.802 |
MDCK | -4.94 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.674 | PPB | 97.205 |
VD | 1.763 | Fu | 1.322 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.207 | CYP1A2 substrate | 0.809 |
CYP2A6 substrate | 0.843 | CYP2B6 substrate | 0.693 |
CYP2C19 inhibitor | 0.963 | CYP2C19 substrate | 0.956 |
CYP2C8 substrate | 0.935 | CYP2C9 inhibitor | 0.556 |
CYP2C9 substrate | 0.981 | CYP2D6 inhibitor | 0.995 |
CYP2D6 substrate | 0.997 | CYP2E1 substrate | 0.879 |
CYP3A4 inhibitor | 0.317 | CYP3A4 substrate | 0.982 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.148 | CL | 9.694 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.998 | Hepatotoxicity | 0.964 |
Mutagenicity | 0.0 | Rat Oral Acute Toxicity | 0.793 |
FDAMDD | 0.655 | Skin Sensitization | 0.908 |
Carcinogenicity | 0.059 | Eye Corrosion | 0.001 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.837 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.668 | IGC50 | 3.448 |
LC50FM | 1.891 | LC50DM | -0.679 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.384 | NR-AR-LBD | 0.19 |
NR-AhR | 0.633 | NR-Aromatase | 0.028 |
NR-ER | 0.352 | NR-ER-LBD | 0.297 |
NR-PPAR-gamma | 0.182 | SR-ARE | 0.874 |
SR-ATAD5 | 0.334 | SR-HSE | 0.116 |
SR-MMP | 0.052 | SR-p53 | 0.059 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.